Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Stefano Zancan

Stefano Zancan

Head of Clinical Development, Telethon

I have been working in  clinical research  for more than 20 years, mainly in GSK but also in Novartis and Aptuit, managing a portfolio of clinical projects and  leading a group of scientists accountable for the end to end operational management of the assigned clinical studies from concept protocol to final reporting.  Experienced in data protection in clinical trials, quality and GCP.

I currenty am head of Clinical Development and Operations in Fondazione Telethon, contributing to move projects from basic research to clinical research and leading subsequent clinical operations activities. 

I’m also Head od Just Like Home program, a program Fondazione Telethon has set to support patient to get access to Gene Therapies

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd